Newswise COVID Experts

Filters close
access_time Embargo lifts in 2 days
Embargo will expire: 23-May-2024 5:00 AM EDT Released to reporters: 21-May-2024 6:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-May-2024 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

Embargo will expire: 20-May-2024 5:00 PM EDT Released to reporters: 14-May-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 20-May-2024 2:05 PM EDT
COVID-19 Impacted Domestic Violence Differently Depending on Class, but Not in the Way You May Think: New Study
American Sociological Association (ASA)

New sociological research that looks into how crisis conditions during the pandemic—such as poor heath and insecure housing—affected domestic abuse and victims’ interpretation of violence.

   
Released: 20-May-2024 11:05 AM EDT
Is a Global Pandemic Prevention Pact Within Reach?
Harvard Medical School

The World Health Organization’s governing body is scheduled to meet on May 27 to discuss a critically needed plan for global pandemic preparedness.

Newswise: Not sure about vaccines? How public health messaging is framed makes a difference, new research reveals
Released: 20-May-2024 10:05 AM EDT
Not sure about vaccines? How public health messaging is framed makes a difference, new research reveals
Binghamton University, State University of New York

What’s the best way to communicate with a vaccine-hesitant person about a vaccine’s potential benefits? New research from Binghamton University, State University of New York found that a one-size-fits-all approach to communicating messages isn’t effective.

Newswise: Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
Released: 17-May-2024 1:05 PM EDT
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
Washington University in St. Louis

A study by researchers at Washington University School of Medicine in St. Louis has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes COVID-19, as well as related coronaviruses.

Newswise: Vivek%20Kumar%20with%20hydrogels-resize.jpg?itok=Ls_qh5Tc
Released: 17-May-2024 1:05 PM EDT
NJIT Engineers Muffle Invading Pathogens with a 'Molecular Mask'
New Jersey Institute of Technology (NJIT)

Vaccines remain the gold standard of protection against dangerous pathogens, but take considerable time and vast resources to develop. Rapidly mutating viruses such as SARS-CoV-2 can blunt their effectiveness and even render them obsolete.

   


close
2.50997